Image

Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Quadriceps Strength in Athletes With Patellar Tendinopathy

Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Quadriceps Strength in Athletes With Patellar Tendinopathy

Recruiting
18-40 years
Male
Phase N/A

Powered by AI

Overview

This study investigates the immediate effects of different peripheral electrical nerve stimulation protocols applied to the femoral nerve on quadriceps strength in athletes with patellar tendinopathy. Patellar tendinopathy is a common overuse injury that often reduces quadriceps activation and limits sports performance. Peripheral percutaneous nerve stimulation (PPNS) and transcutaneous electrical nerve stimulation (TENS) are frequently used in rehabilitation, but their frequency-dependent effects on muscle strength are not well established.

In this randomized crossover trial, each participant receives three stimulation protocols in separate sessions: high-frequency PPNS (100 Hz), low-frequency PPNS (2 Hz), and conventional TENS. All stimulation is delivered at the maximal tolerated motor threshold and, for PPNS conditions, under ultrasound guidance. Quadriceps maximal isometric strength is evaluated using an isometric force sensor before and after each intervention.

The primary objective is to compare the acute changes in maximal voluntary contraction (MVC) following each stimulation protocol. The study aims to clarify whether different stimulation frequencies can enhance, reduce, or have no effect on quadriceps strength in this athletic population.

By identifying frequency-specific neuromodulatory responses, this study may help clinicians and sports practitioners select the most appropriate stimulation parameters to optimize rehabilitation and performance in individuals with patellar tendinopathy.

Eligibility

Inclusion Criteria:

  • Adults aged 18 to 40 years.
  • Recreational or competitive athletes with clinically diagnosed patellar tendinopathy for at least 3 months.
  • Ultrasound-confirmed patellar tendinopathy, including hypoechoic areas, tendon thickening, or neovascularization consistent with clinical diagnosis.

Presence of pain during tendon-loading activities (e.g., jumping, running, squatting).

  • Ability to perform maximal voluntary isometric contractions of the quadriceps.
  • Ability to comply with all study procedures and attend all experimental sessions.
  • Written informed consent obtained prior to participation.

Exclusion Criteria:

  • Previous knee surgery or traumatic knee injury within the past 12 months.
  • Complete or partial patellar tendon rupture.
  • Neurological disorders affecting lower limb strength or motor control.
  • Contraindications to electrical stimulation, including implanted electrical devices (e.g., pacemaker).
  • Current lower-limb radiculopathy or neuropathy.
  • Skin infections, open wounds, or dermatological conditions at the stimulation site.
  • Use of analgesics, anti-inflammatories, or corticosteroid injections within the past 48 hours.
  • Participation in another interventional study in the previous 30 days.
  • Pregnancy or suspected pregnancy.

Study details
    Patellar Tendinopathy / Jumpers Knee

NCT07237867

Hospital Clinic of Barcelona

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.